Anti-DUSP6 antibody [EPR129Y]

12 product images

• 

  Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Lanes 1 - 3: Merged signal (red and green). Green - ab76310 observed at 42 kDa. Red - loading control, Anti-Vinculin antibody [VIN-54] ab130007, observed at 130 kDa.
  

  ab76310 was shown to recognize in wild-type A431 cells as signal was lost at the expected MW in DUSP6 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and DUSP6 knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% Milk. ab76310 and Anti-Vinculin antibody [VIN-54] ab130007 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/500 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye^® 680RD) preabsorbed Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

  All lanes: Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310) at 1/500 dilution

  Lane 1: Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg

  Lane 2: DUSP6 knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg

  Lane 2: Western blot - Human DUSP6 knockout A-431 cell line (Human DUSP6 knockout A-431 cell line ab261885)

  Lane 3: HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

  Performed under reducing conditions.

  Predicted band size: 42 kDa

• 

  Schmidt C et al., Front Immunol, 9, 2386, 2018 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

  Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Immunoblot analysis of indicated proteins in splenocytes after CD4+ sort, liver homogenate or purified CD4+ T cells from WT, DUSP6+/- or DUSP6-/- mice to confirm knockout or heterozygosity for DUSP6 at protein level.
  

  This image was generated using Anti-DUSP6 antibody [EPR129Y] - BSA and Azide free ab220811, the same antibody but in a PBS-only buffer formulation.

  All lanes: Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Predicted band size: 42 kDa

• 

  Immunoprecipitation - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  ab76310 (purified) at 1/20 immunoprecipitating DUSP6 in 10 μg NIH-3T3 (Lanes 1 and 2, observed at 42 and 44 kDa). Lane 3 - PBS. For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500). Blocking buffer and concentration: 5% NFDM/TBST Dilution buffer and concentration: 5% NFDM/TBST

  All lanes: Immunoprecipitation - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Predicted band size: 42 kDa

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Immunohistochemical staining of paraffin embedded human pancreas with purified ab76310 at a working dilution of 1/100. The secondary antibody used is HRP goat anti-rabbit IgG H&L (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.

• 

  Flow Cytometry (Intracellular) - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Overlay histogram showing NIH-3T3 cells fixed in 4% PFA and stained with purified ab76310 at a dilution of 1 in 200 (red line). The secondary antibody used was FITC goat anti-rabbit at a dilution of 1 in 500. Rabbit monoclonal IgG was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).

• 

  Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Blocking buffer: 5% NFDM/TBST
  Dilution buffer: 5% NFDM/TBST

  ab76310 detects an unspecific band around 100 kDa in human materials.

  All lanes: Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310) at 1/5000 dilution

  All lanes: HepG2 cell lysate at 20 µg

  Secondary

  All lanes: HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution

  Predicted band size: 42 kDa

  Observed band size: 42 kDa, 44 kDa

• 

  Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Blocking buffer: 5% NFDM/TBST
  Dilution buffer: 5% NFDM/TBST

  All lanes: Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310) at 1/1000 dilution

  Lane 1: rat brain lysate at 20 µg

  Lane 2: NIH/3T3 cell lysate at 20 µg

  Secondary

  All lanes: HRP goat anti-rabbit IgG (H+L) at 1/1000 dilution

  Predicted band size: 42 kDa

  Observed band size: 42 kDa, 44 kDa

• 

  Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Blocking buffer: 5% NFDM/TBST
  Dilution buffer: 5% NFDM/TBST

  All lanes: Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310) at 1/1000 dilution

  All lanes: mouse brain at 10 µg

  Secondary

  All lanes: HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution

  Predicted band size: 42 kDa

  Observed band size: 42 kDa, 44 kDa

• 

  Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  All lanes: Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310) at 1/500 dilution

  All lanes: 3T3 cell lysate at 10 µg

  Secondary

  All lanes: HRP labelled goat anti-rabbit at 1/2000 dilution

  Predicted band size: 42 kDa

  Observed band size: 42 kDa, 44 kDa

• 

  This image was taken from a customer review by Graeme Stewart.

  Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  All lanes: Western blot - Anti-DUSP6 antibody [EPR129Y] (ab76310) at 1/4000 dilution

  Lane 1: Marker

  Lane 2: Lysate from wild type primary murine embryonic fibroblasts (MEFs) untreated at 10 µg

  Lane 3: Lysate from wild type primary murine embryonic fibroblasts (MEFs) treated with 100ngµl-1, 12-O-tetradecanoylphorbol-13-acetate (TPA) for 2 hours at 10 µg

  Lane 4: Lysate from MKP-3 null primary murine embryonic fibroblasts (MEFs) untreated at 10 µg

  Lane 5: Lysate from MKP-3 null primary murine embryonic fibroblasts (MEFs) treated with 100ngµl-1, 12-O-tetradecanoylphorbol-13-acetate (TPA) for 2 hours at 10 µg

  Secondary

  All lanes: Goat anti Rabbit HRP conjugate at 1/10000 dilution

  Developed using the ECL technique.

  Performed under reducing conditions.

  Predicted band size: 42 kDa

  Observed band size: 42 kDa

  Exposure time: 2min

• 

  Flow Cytometry (Intracellular) - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Overlay histogram showing HeLa cells stained with unpurifiedab76310 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76310, 1/20 dilution) for 30 min at 22°C. The secondary antibody used was DyLight^® 488 goat anti-rabbit IgG (H+L) (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1μg/1x10⁶ cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde/permeabilized with 0.1% PBS-Tween 20 used under the same conditions.
  

• 

  Immunohistochemistry - Anti-DUSP6 antibody [EPR129Y] (ab76310)

  Immunohistochemical analysis of formalin fixed paraffin embedded human pancreas labelling DUSP6 with ab76310 at a concentration of 0.5 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH 8.5 for 32 mins.

  ab76310 anti-DUSP6 [EPR129Y] was incubated for 16 mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

  Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).